Correlation Between Cyclacel Pharmaceuticals and OncoSec Medical
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and OncoSec Medical, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and OncoSec Medical.
Diversification Opportunities for Cyclacel Pharmaceuticals and OncoSec Medical
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Cyclacel and OncoSec is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and OncoSec Medical go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and OncoSec Medical
Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to generate 0.52 times more return on investment than OncoSec Medical. However, Cyclacel Pharmaceuticals is 1.91 times less risky than OncoSec Medical. It trades about -0.06 of its potential returns per unit of risk. OncoSec Medical is currently generating about -0.29 per unit of risk. If you would invest 1,020 in Cyclacel Pharmaceuticals on August 31, 2024 and sell it today you would lose (979.00) from holding Cyclacel Pharmaceuticals or give up 95.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 8.56% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. OncoSec Medical
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| OncoSec Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cyclacel Pharmaceuticals and OncoSec Medical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and OncoSec Medical
The main advantage of trading using opposite Cyclacel Pharmaceuticals and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
| OncoSec Medical vs. ZyVersa Therapeutics | OncoSec Medical vs. Palisade Bio | OncoSec Medical vs. Unicycive Therapeutics | OncoSec Medical vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |